

Psychedelics for mental illness
Dec 11, 2021
Explore the potential use of psychedelics in treating mental health issues, focusing on the benefits for PTSD and the recent phase three trial using MDMA. Discuss the criteria for participants in PTSD studies and the findings of a study comparing MDMA therapy with a placebo. Compare the effects of psilocybin and Essatalopram on individuals with depression. Look towards the future of psychedelics in psychiatry and discuss the potential of psychedelic-assisted therapy for individuals with terminal illnesses.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
The Psychedelic Renaissance and a Phase Three Trial for MDMA-Assisted Therapy for PTSD
01:34 • 2min
MDMA Therapy for PTSD and its Effects
03:08 • 9min
Psilocybin vs Essapalopram: A Comparison
12:28 • 4min
Looking towards the future of psychedelics for mental illness
16:42 • 2min
Psychedelic Assisted Therapy for Individuals with Terminal Illness
18:17 • 11min